Navigation Links
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Date:2/14/2008

905) (378,739)

Changes in assets and liabilities:

Prepaid expenses and other

current assets 168,987 270,745

Deposits - 690,000

Accounts payable 204,029 526,711

Accrued expenses 3,465,028 3,811,373

Deferred grant revenue (147,464) -

Other liabilities 86,644 234,833

Net cash used in operating

activities (51,641,258) (51,619,518)

Cash flows from investing activities:

Purchases of property and equipment (279,433) (1,354,156)

Proceeds from sales of property

and equipment 200,179 -

Purchases of marketable securities (138,953,879) (102,232,608)

Proceeds from sales of marketable

securities 3,577,859 82,137,888

Maturities of marketable securities 86,695,000 29,670,000

Net cash provided by (used in)

investing activities (48,760,274) 8,221,124

Cash flows from financing activities:

Principal payments on obligations

under capital lease - (1,540)

Principal payments on note payable - (141,074)

Proceeds from exercise of stock options

and warrants 148,640 127,115

Proceeds from issuance of common stock,

net of issuance costs 111,254,850 53,329,951

Net cash provided by

financing activities 111,403,490 53,314,452

Effect of foreign currency translation (1,320) 22

Net incr
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Vion Pharmaceuticals Holds Special Meeting of Stockholders
2. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
3. Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement
4. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
5. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
6. Access Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
7. XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development
9. Onyx Pharmaceuticals to Present at BIO CEO & Investor Conference
10. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
11. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... -- Five American winners will receive the ... for Medical Sciences", in its 8 th term; ... , on 15 December 2014.      (Photo: ... Center which won the Hamdan Award for Volunteers in ... that aim to improve health and promote peace and ...
(Date:11/24/2014)... 2014   Veracyte, Inc. (Nasdaq: VCYT ... and chief executive officer, will present in a fireside chat ... Conference on Tuesday, December 2, 2014 at 12:30 p.m. ET ... live audio webcast and subsequent replay may be accessed by ... the website at least 15 minutes prior to the live ...
(Date:11/24/2014)... November 24, 2014 The new ... from METTLER TOLEDO demonstrates how to reduce the ... analytics and sample panel design can be complicated, ... and protect against corrosion and deposition. Dedicated single ... significant amount of panel space. Additionally, installing and ...
(Date:11/22/2014)... PA and London (PRWEB) November 21, 2014 ... December will explore what comes next for ALS research and ... sites. , After the Ice Bucket Challenge: Where Does ... Cudkowicz, Date: Tuesday, 2 December 2014, Time: 1:30pm ... , Join expert speaker Dr. Merit Cudkowicz, Julianne Dorn ...
Breaking Biology Technology:Five US Winners Among Recipients of Hamdan Medical Awards 2Veracyte to Present at the Piper Jaffray 26th Annual Healthcare Conference 2New Video Shows How to Simplify Cycle Chemistry Sample Panels to Save Time and Costs 2DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites 2
... Additional donations to benefit St. Jude Children,s Research Hospital(R), ... by ... visiting promesayesperanza.org, MEMPHIS, Tenn., Feb. 14 More ... Esperanza (Promise and,Hope) radiothon held by Univision Radio, a division ...
... Feb. 14 CV Therapeutics,Inc. (Nasdaq: CVTX ... rule 4350, the Company issued new inducement stock ... hiring, primarily in,connection with its commercialization efforts in ... cover an aggregate 119,200 shares of,common stock and ...
... the,availability of MarketStats on public equities that are ... can view all of SectorWatch.biz MarketStats free of ... MarketStats, Today,s MarketStats on Healthcare and Biotechnology ... CVBT), Boston,Scientific Corp. (NYSE: BSX ), Medtronic ...
Cached Biology Technology:More than $6 Million Raised During Two-Day Event to Support Research and Treatment for Childhood Cancer and Other Catastrophic Diseases 2More than $6 Million Raised During Two-Day Event to Support Research and Treatment for Childhood Cancer and Other Catastrophic Diseases 3CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350 2SectorWatch.biz Issues MarketStats on CVBT, BSX, MDT, CXM and DNA 2
(Date:11/18/2014)... YORK , Nov. 18, 2014   ... identity authentication solutions, and MorphoTrust USA ... and services, today announced a strategic partnership to ... enterprise, motor vehicle administration (MVA), airport screening and ... in identity-related solutions, MorphoTrust serves consumers through a ...
(Date:11/10/2014)... appearing on U.S. store shelves in early 2010, and ... The small packets can be tossed into a washing ... or powder. The convenience, though, has come with risks ... at Nationwide Children,s Hospital found that from 2012 through ... children younger than 6 years of age swallowing, inhaling, ...
(Date:11/6/2014)... -- A groundbreaking paper from a team of Florida ... of how plants could adapt to and survive environmental ... published in the latest issue of the journal ... (the complex of DNA and proteins) is organized in ... that some genes are turned on and others are ...
Breaking Biology News(10 mins):EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Study finds laundry detergent pods, serious poisoning risk for children 2Maize analysis yields whole new world of genetic science 2
... Health & Science University Doernbecher Children,s Hospital are the ... reveal tiny white matter injuries in the developing brain ... identification of these lesions in the preterm human infant ... inform families sooner of the potential for complications. The ...
... RIKEN Brain Science Institute (BSI) have discovered a key ... from the cell. Their findings indicate that the capture ... phosphorylation of a protein called p62, opening the door ... Huntington,s disease and Alzheimer,s disease. One of the ...
... system is of the greatest importance for us to understand ... Uppsala University have examined the key step when genes are ... brain are transcribed with a special mechanism. The findings, reported ... can be of importance in our understanding of the genetic ...
Cached Biology News:First use of high-field MRI in developing brain reveals previously undetectable injuries 2Process important to brain development studied in detail 2
... dye for nucleic acid electrophoresis in ... sequencing. Preparation Quantity Equivalency: A final ... 2% stock solution can be made ... comp: Dye content ~ 75% ...
... top performance with exquisite design. The 96 ... unparalleled temperature uniformity. The instrument has a ... spreadsheet or alternatively in a graphical mode. ... the push of a button and swings ...
... The VSN-5 Nutating Mixer is a ... which produces a three dimensional action while ... This high quality unit can be used ... or resuspension of specimens, tissue culture, immunoblots, ...
... designed for the rapid purification of linear 100 ... The DNA band is excised from an,agarose gel ... the base of the column are a series ... impurities back while allowing DNA to selectively pass ...
Biology Products: